All Comments by Alexei Koudinov

  1. Long-term accumulation of amyloid-beta in axons following brain trauma without persistent upregulation of amyloid precursor protein genes.
  2. Are beta-sheet breaker peptides dissolving the therapeutic problem of Alzheimer's disease?
  3. Modification of the monoaminergic neurotransmitters in frontal cortex and hippocampus by dietary trans alpha-linolenic acid in piglets.
  4. The neurodegeneration mutant löchrig interferes with cholesterol homeostasis and Appl processing.
  5. BSE prions propagate as either variant CJD-like or sporadic CJD-like prion strains in transgenic mice expressing human prion protein.
  6. Amyloidosis and Alzheimer's disease.
  7. Gamma-secretase inhibitors and Alzheimer's disease.
  8. Abeta immunization and anti-Abeta antibodies: potential therapies for the prevention and treatment of Alzheimer's disease.
  9. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics.
  10. Deciphering the genesis and fate of amyloid beta-protein yields novel therapies for Alzheimer disease.
  11. Can Travel, Will Deposit: Aβ via the Perforant Pathway?
  12. Rescue of neurodegeneration in Niemann-Pick C mice by a prion-promoter-driven Npc1 cDNA transgene.
  13. Cholesterol and Alzheimer's—Charging Fast But Still at a Distance from Solid Answers
  14. Function of beta-amyloid in cholesterol transport: a lead to neurotoxicity.
  15. Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's disease.